Cost & Insurance

GLP-1 Medication Costs: Pricing, Insurance Coverage & Savings Programs

GLP-1 Companion · 8 min read

The cost question that matters is not "what is the list price of Ozempic or Wegovy?" It is "what will I personally pay after my diagnosis, insurance rules, pharmacy path, savings-card eligibility, visit fees, and refills are included?"

My position: do the cost work before the first fill. Too many patients start with a coupon, then discover the real monthly number at refill or renewal. A sustainable GLP-1 plan needs a backup path before the first payment.

Retail Prices of Popular GLP-1 Medications

List prices for GLP-1 medications vary by drug, dosage, and pharmacy. These are approximate retail prices without insurance as of early 2026.

• Wegovy (semaglutide for weight loss): approximately $1,300 to $1,400 per month
• Ozempic (semaglutide for type 2 diabetes): approximately $900 to $1,000 per month
• Mounjaro (tirzepatide for type 2 diabetes): approximately $1,000 to $1,100 per month
• Zepbound (tirzepatide for weight loss): approximately $1,000 to $1,100 per month
• Saxenda (liraglutide for weight loss): approximately $1,300 to $1,500 per month
• Rybelsus (oral semaglutide for type 2 diabetes): approximately $900 to $1,000 per month

Insurance Coverage for GLP-1 Medications

Insurance coverage for GLP-1 medications varies widely depending on your plan type, the specific medication, and the indication it is prescribed for. Generally, medications prescribed for type 2 diabetes have broader coverage than those prescribed purely for weight loss, though this gap is narrowing as insurers recognize the long-term health benefits of treating obesity.

Private Insurance and Employer Plans

Many private insurance plans and employer-sponsored plans now cover at least one GLP-1 medication on their formulary. Coverage often requires prior authorization, meaning your doctor must submit documentation demonstrating medical necessity. Common requirements include a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or sleep apnea. Copays on covered plans typically range from $25 to $150 per month depending on the tier placement.

Medicare and Medicaid

Medicare Part D covers GLP-1 medications for type 2 diabetes but historically has not covered them for weight loss alone. However, legislative efforts including the Treat and Reduce Obesity Act have been pushing to expand Medicare coverage for anti-obesity medications. Medicaid coverage varies by state; some states cover weight loss medications while others restrict coverage to diabetes indications only. Check your state Medicaid formulary or contact your plan directly for the most current information.

Tips for Improving Your Insurance Coverage

1. Ask your doctor about the prior authorization process and what documentation is needed.
2. Request a letter of medical necessity that outlines your health history and why a GLP-1 medication is appropriate.
3. If your first medication is denied, ask about covered alternatives on the formulary or file a formal appeal.
4. Check whether a diabetes diagnosis alongside obesity changes your coverage eligibility.
5. Contact your insurance company directly to confirm formulary placement and tier status before filling a prescription.

Manufacturer Savings Cards and Copay Programs

Both Novo Nordisk and Eli Lilly offer savings programs that can significantly reduce out-of-pocket costs for eligible patients. These programs are typically available to patients with commercial insurance and are not available to those on government-funded plans like Medicare, Medicaid, or Tricare.

• Novo Nordisk Savings Card: eligible patients may pay as little as $0 to $25 per month for Wegovy or Ozempic for a specified period.
• Lilly Savings Card: eligible patients may pay as little as $25 per month for Mounjaro or Zepbound.
• These offers may have monthly or annual caps on savings and typically require re-enrollment each year.
• Eligibility requirements include having commercial insurance and not being enrolled in any government-funded healthcare program.

Patient Assistance Programs (PAPs)

For patients who are uninsured or underinsured, manufacturer-sponsored patient assistance programs may provide the medication at no cost. These programs are income-based and typically require proof that household income falls below a certain threshold, often 400 percent of the federal poverty level.

• Novo Nordisk Patient Assistance Program (NovoCare): provides free medication to qualifying uninsured patients.
• Lilly Cares Foundation: offers free Mounjaro and Zepbound to eligible uninsured patients.
• Applications typically require proof of income, a prescription, and a signed form from your healthcare provider.
• Approval timelines vary but usually take two to four weeks.

Compounded GLP-1 Alternatives

Compounding pharmacies have entered the GLP-1 market by producing custom formulations of semaglutide and tirzepatide, often at significantly lower prices than brand-name versions. These compounded medications are typically available only when the brand-name drug is listed on the FDA drug shortage list. Prices for compounded semaglutide generally range from $150 to $500 per month depending on the dose and pharmacy.

Additional Tips for Reducing Your GLP-1 Costs

1. Compare prices across pharmacies using tools like GoodRx or RxSaver, as cash prices can vary by hundreds of dollars between pharmacies.
2. Ask your prescriber about dose optimization; some patients achieve results at lower doses, which may cost less.
3. Consider mail-order pharmacies, which often offer 90-day supplies at a discount compared to 30-day retail fills.
4. Look into Health Savings Accounts (HSAs) or Flexible Spending Accounts (FSAs) to pay with pre-tax dollars.
5. Check for state-specific programs; some states have pharmaceutical assistance programs for residents who do not qualify for federal aid.
6. Ask your doctor about clinical trials, which may provide the medication at no cost while contributing to research.

Cost should never be the sole reason someone avoids a medication that could improve their health. Explore every option and work with your healthcare team to find a path that works for your budget.

The Bottom Line

GLP-1 medications carry high list prices, but the amount you actually pay can be much lower. Between insurance coverage, manufacturer savings programs, patient assistance, and legitimate telehealth options, there are multiple strategies to bring costs down. Start by understanding your insurance benefits, then layer in any available savings programs. If you are still facing a financial barrier, compare licensed provider options through /partners and ask each one for the real monthly cost before paying.

Sources

• Wilding et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM.
• Jastreboff et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. NEJM.